Type of vascular access and mortality in U.S. hemodialysis patients

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Volume 82, Issue 12, Pages (December 2012)

Michael Allon, Michelle L. Robbin Kidney International

First-year death rates by modality figure 8

Ann Intern Med. 2000;133(6): doi: / Figure Legend:

Patient populations by study group figure 10

Treatment of acute renal failure

Central venous catheter outcomes in nocturnal hemodialysis

Volume 81, Issue 5, Pages (March 2012)

Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,

Mae Thamer, Timmy C. Lee, Haimanot Wasse, Marc H

Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.

Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick

Anemia management in chronic kidney disease

Volume 63, Issue 1, Pages (January 2003)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Volume 64, Pages S3-S12 (December 2003)

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 64, Issue 3, Pages (September 2003)

IP155. Transplant Wait Listing Attenuates the Association Between Hemodialysis Access and Mortality Courtenay Holscher, Sunjae Bae, Christine Haugen,

Volume 82, Issue 12, Pages (December 2012)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 85, Issue 1, Pages (January 2014)

Molly E. Waring, PhD, Jane S

Satinderjit Locham, Apurva B

Survival advantage in Asian American end-stage renal disease patients1

Volume 68, Issue 5, Pages (November 2005)

Patient selection affects end-stage renal disease outcome comparisons

Volume 77, Issue 7, Pages (April 2010)

Treatment of acute renal failure

The epidemiology of chronic kidney disease

Stephen P. McDonald Kidney International Supplements

Volume 62, Issue 6, Pages (December 2002)

Body size and outcomes on peritoneal dialysis in the United States

Michael D. Sgroi, MD, Madhukar S. Patel, MD, Samuel E

Volume 70, Issue 12, Pages (December 2006)

Caitlin W. Hicks, MD, MS, Joseph K

Volume 81, Issue 5, Pages (March 2012)

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Volume 62, Issue 5, Pages (November 2002)

Volume 64, Issue 1, Pages (July 2003)

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients Bernard G. Jaar, Brad C. Astor, Jeffrey S.

Volume 80, Issue 6, Pages (September 2011)

David A. Goodkin, MD, Eric W

Volume 84, Issue 4, Pages (October 2013)

Volume 72, Issue 4, Pages (August 2007)

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 64, Issue 2, Pages (August 2003)

Volume 82, Issue 3, Pages (August 2012)

Volume 68, Issue 1, Pages (July 2005)

Long-term survival in renal transplant recipients with graft function

Current status of maintenance hemodialysis in Beijing, China

Volume 61, Issue 1, Pages (January 2002)

Volume 70, Issue 8, Pages (October 2006)

Volume 66, Issue 6, Pages (December 2004)

Volume 64, Issue 5, Pages (November 2003)

Volume 75, Issue 1, Pages (January 2009)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Vitamin D deficiency and anemia in early chronic kidney disease

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Volume 61, Issue 2, Pages (February 2002)

Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists Gerald A. Beathard, Terry Litchfield Kidney.

Central venous catheter outcomes in nocturnal hemodialysis

Stephen Pastan, J. Michael Soucie, William M. McClellan

Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation Theodore.

Effect of Severe Anemia on Outcomes of Hemodialysis Vascular Access

Presentation transcript:

Type of vascular access and mortality in U.S. hemodialysis patients Rajnish K. Dhingra, Eric W. Young, T.E. Hulbert-Shearon, Sean F. Leavey, Friedrich K. Port Kidney International Volume 60, Issue 4, Pages 1443-1451 (October 2001) DOI: 10.1046/j.1523-1755.2001.00947.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Adjusted patient survival (Cox)* for various vascular access (VA) types [arteriovenous fistula (AVF); arteriovenous graft (AVG); central venous catheter (CVG)] in prevalent diabetic patients. *Adjusted for the average diabetic patient overall (Cox). Covariates in the model included age, race, gender, body mass index (BMI), history of smoking, peripheral vascular disease (PVD), coronary artery disease (CAD), chronic heart failure (CHF), neoplasm, ability to ambulate, and education level. Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted patient survival (Cox)* for various VA types in prevalent nondiabetic patients. *Adjusted for the average diabetic patient overall (Cox). Covariates in the model included age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate, and education level. Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Adjusted* relative risk of death by VA types among diabetic patients. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.42). Incident diabetic patients: CVC vs. AVG (P = 0.48). Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Adjusted* relative risk of death by VA types among nondiabetic patients. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent nondiabetic patients: CVC vs. AVG (P < 0.0001). Incident nondiabetic patients: CVC vs. AVG (P = 0.82). Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Adjusted* relative risk of death due to cardiac causes by VA type and diabetes status. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.59). Prevalent nondiabetic patients: CVC vs. AVG (P = 0.003). Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Adjusted* relative risk of death due to infection by VA type and diabetes status. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.81). Prevalent nondiabetic patients: CVC vs. AVG (P = 0.13). Kidney International 2001 60, 1443-1451DOI: (10.1046/j.1523-1755.2001.00947.x) Copyright © 2001 International Society of Nephrology Terms and Conditions